Adult Choroid Plexus Cancer

Categories: Cancer diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Adult Choroid Plexus Cancer

MalaCards integrated aliases for Adult Choroid Plexus Cancer:

Name: Adult Choroid Plexus Cancer 12
Adult Choroid Plexus Tumor 12 74
Neoplasm of the Adult Choroid Plexus 12


External Ids:

Disease Ontology 12 DOID:3542
NCIt 51 C8568
UMLS 74 C0796430

Summaries for Adult Choroid Plexus Cancer

MalaCards based summary : Adult Choroid Plexus Cancer, is also known as adult choroid plexus tumor, and has symptoms including vomiting and headache. The drugs Fentanyl and Donepezil have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and liver.

Related Diseases for Adult Choroid Plexus Cancer

Diseases in the Choroid Plexus Cancer family:

Adult Choroid Plexus Cancer

Symptoms & Phenotypes for Adult Choroid Plexus Cancer

UMLS symptoms related to Adult Choroid Plexus Cancer:

vomiting, headache

Drugs & Therapeutics for Adult Choroid Plexus Cancer

Drugs for Adult Choroid Plexus Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 90)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
3 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
4 Narcotics Phase 3
5 Adjuvants, Anesthesia Phase 3
6 Analgesics Phase 3
7 Anesthetics, Intravenous Phase 3
8 Liver Extracts Phase 3,Phase 1
9 Anesthetics, General Phase 3
10 Anesthetics Phase 3
11 Analgesics, Opioid Phase 3
12 Central Nervous System Depressants Phase 3
13 Peripheral Nervous System Agents Phase 3
14 Cola Phase 3,Phase 1
15 Cholinesterase Inhibitors Phase 3,Phase 2
16 Neurotransmitter Agents Phase 3,Phase 2
17 Nootropic Agents Phase 3,Phase 2
18 Cholinergic Agents Phase 3,Phase 2
Bevacizumab Approved, Investigational Phase 2 216974-75-3
Aldesleukin Approved Phase 2 110942-02-4, 85898-30-2
Paclitaxel Approved, Vet_approved Phase 2,Phase 1 33069-62-4 36314
Carmustine Approved, Investigational Phase 2 154-93-8 2578
Lenograstim Approved, Investigational Phase 2 135968-09-1
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
Sargramostim Approved, Investigational Phase 2 123774-72-1, 83869-56-1
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
27 Immunologic Factors Phase 2,Phase 1
28 Angiogenesis Modulating Agents Phase 2,Phase 1
29 Antineoplastic Agents, Immunological Phase 2
30 Angiogenesis Inhibitors Phase 2,Phase 1
31 Immunoglobulins Phase 2
32 Antibodies Phase 2
33 Antibodies, Monoclonal Phase 2
34 Anti-Retroviral Agents Phase 2
35 Antiviral Agents Phase 2
36 Interleukin-2 Phase 2
37 Anti-HIV Agents Phase 2
38 Antirheumatic Agents Phase 2
39 Antineoplastic Agents, Alkylating Phase 2,Phase 1
40 Anti-Infective Agents Phase 2,Phase 1
41 Albumin-Bound Paclitaxel Phase 2,Phase 1
42 Alkylating Agents Phase 2,Phase 1
43 Vaccines Phase 2
44 Immunosuppressive Agents Phase 2,Phase 1
45 Ginkgo Phase 2
Verteporfin Approved, Investigational Phase 1 129497-78-5
Trioxsalen Approved Phase 1 3902-71-4 5585
Miconazole Approved, Investigational, Vet_approved Phase 1 22916-47-8 4189
Sirolimus Approved, Investigational Phase 1 53123-88-9 46835353 5284616 6436030
Everolimus Approved Phase 1 159351-69-6 70789204 6442177

Interventional clinical trials:

(show all 24)
# Name Status NCT ID Phase Drugs
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
3 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
4 Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer Completed NCT00014573 Phase 2 carmustine;cisplatin;cyclophosphamide;paclitaxel
5 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
6 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
7 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914 Phase 1 temsirolimus
8 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
9 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1 bortezomib;temozolomide
10 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
11 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
12 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
13 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
14 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel
15 Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors Terminated NCT00110032 Phase 1 EF5
16 Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Unknown status NCT00757614
17 Study of Tissue Samples From Patients With Glioma or Other Brain Tumors Completed NCT00967200
18 Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial Completed NCT00890435
19 Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors Completed NCT00499798
20 Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders Completed NCT00255671
21 Yoga Therapy in Treating Patients With Malignant Brain Tumors Terminated NCT01234805 Not Applicable
22 Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Terminated NCT02967380 Not Applicable Gadobenate Dimeglumine;Gadobutrol
23 Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Withdrawn NCT02194452 Not Applicable
24 Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors Withdrawn NCT00005790 Not Applicable

Search NIH Clinical Center for Adult Choroid Plexus Cancer

Genetic Tests for Adult Choroid Plexus Cancer

Anatomical Context for Adult Choroid Plexus Cancer

MalaCards organs/tissues related to Adult Choroid Plexus Cancer:

Brain, Bone, Liver, Bone Marrow

Publications for Adult Choroid Plexus Cancer

Variations for Adult Choroid Plexus Cancer

Expression for Adult Choroid Plexus Cancer

Search GEO for disease gene expression data for Adult Choroid Plexus Cancer.

Pathways for Adult Choroid Plexus Cancer

GO Terms for Adult Choroid Plexus Cancer

Sources for Adult Choroid Plexus Cancer

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
33 HPO
34 ICD10
35 ICD10 via Orphanet
39 LifeMap
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
56 Novoseek
59 OMIM via Orphanet
63 PubMed
71 SNOMED-CT via Orphanet
73 Tocris
75 UMLS via Orphanet
Loading form....